Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

IPH

Innate Pharma (IPH)

Innate Pharma
De:
Trier par:
 Showing the most relevant articles for your search:EU:IPH
DateHeureSourceTitreSymboleSociété
19/12/202313h38MF Dow Jones (Italiano)Le azioni di Innate Pharma salgono dopo l'esercizio dell'opzione dilicenza da parte di SanofiEU:IPHInnate Pharma
19/12/202313h28Dow Jones NewsInnate Pharma Shares Rise after Sanofi Exercises Licensing OptionEU:IPHInnate Pharma
19/12/202308h39Dow Jones NewsSanofi exerce une option de licence en oncologie auprès d'Innate PharmaEU:IPHInnate Pharma
05/10/202314h14Dow Jones NewsInnate Pharma Shares Fall Premarket on FDA Partial Study HoldEU:IPHInnate Pharma
08/06/202316h53Dow Jones NewsInnate Pharma Shares Rise 8% After Cancer Treatment Gets Fast Track DesignationEU:IPHInnate Pharma
19/12/202208h25Dow Jones NewsSanofi et Innate Pharma étendent leur collaboration en oncologie avec les cellules NKEU:IPHInnate Pharma
01/08/202212h30Dow Jones NewsInnate Pharma Shares Slide After Failure of Monalizumab in Head, Neck CancerEU:IPHInnate Pharma
23/09/202107h00GlobeNewswire Inc.Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er septembre 2021EU:IPHInnate Pharma
23/09/202107h00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021EU:IPHInnate Pharma
17/09/202113h45GlobeNewswire Inc.Monalizumab Data From COAST Trial Presented at ESMO Congress 2021EU:IPHInnate Pharma
17/09/202113h45GlobeNewswire Inc.Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021EU:IPHInnate Pharma
17/09/202113h45GlobeNewswire Inc.Monalizumab Data from COAST Trial Presented at ESMO Congress 2021EU:IPHInnate Pharma
15/09/202107h00GlobeNewswire Inc.Innate Pharma reports first half 2021 financial results and business updateEU:IPHInnate Pharma
15/09/202107h00GlobeNewswire Inc.Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2021EU:IPHInnate Pharma
15/09/202107h00GlobeNewswire Inc.Rapport Financier Semestriel 30 juin 2021EU:IPHInnate Pharma
15/09/202107h00GlobeNewswire Inc.Innate Pharma Reports First Half 2021 Financial Results and Business UpdateEU:IPHInnate Pharma
07/09/202107h00GlobeNewswire Inc.Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021EU:IPHInnate Pharma
07/09/202107h00GlobeNewswire Inc.Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business UpdateEU:IPHInnate Pharma
02/09/202108h00GlobeNewswire Inc.Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual CongressEU:IPHInnate Pharma
02/09/202108h00GlobeNewswire Inc.Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021EU:IPHInnate Pharma
02/09/202108h00GlobeNewswire Inc.Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual CongressEU:IPHInnate Pharma
30/08/202107h00GlobeNewswire Inc.Innate Pharma to Participate in Upcoming Investor ConferencesEU:IPHInnate Pharma
30/08/202107h00GlobeNewswire Inc.Prochains Rendez-Vous Investisseurs d'Innate PharmaEU:IPHInnate Pharma
11/08/202107h00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021EU:IPHInnate Pharma
11/08/202107h00GlobeNewswire Inc.Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Aout 2021EU:IPHInnate Pharma
12/07/202107h00GlobeNewswire Inc.NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021EU:IPHInnate Pharma
12/07/202107h00GlobeNewswire Inc.Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Juillet 2021EU:IPHInnate Pharma
12/07/202107h00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021EU:IPHInnate Pharma
06/07/202107h00GlobeNewswire Inc.Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe PneumoniaEU:IPHInnate Pharma
06/07/202107h00GlobeNewswire Inc.Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe PneumoniaEU:IPHInnate Pharma
 Showing the most relevant articles for your search:EU:IPH